Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 2223069Generated: October 31, 2026

Aniline → n'-[7-Chloro-5-(2-chlorophenyl)-2,3-dihydro-1-methyl-2-oxo-1h-1,4-benzodiazepin-3-yl]-n-methyl-n-[2-methyl-4-(4-morpholinyl)phenyl]thiourea

https://huagongshe.com/reaction/2223069

Reaction equation

Participants

RoleNameHCIDCharge
ReactantAnilineHCID 6115—
ReactantMethyl chloroformateHCID 6586—
ReactantDiisopropylethylamineHCID 81531—
Reactant2-Methyl-4-(morpholin-4-yl)anilineHCID 21955000—
Reactant7-Chloro-5-(2-chlorophenyl)-1,3-dihydro-3-isothiocyanato-1-methyl-2h-1,4-benzodiazepin-2-oneHCID 59713976—
SolventDichloromethaneHCID 6344—
Productn'-[7-Chloro-5-(2-chlorophenyl)-2,3-dihydro-1-methyl-2-oxo-1h-1,4-benzodiazepin-3-yl]-n-methyl-n-[2-methyl-4-(4-morpholinyl)phenyl]thioureaHCID 1031215375%

Reaction Steps

A solution of 2-methyl4-(4-morpholinyl)benzenamine (53.3 mg, 0.277 mmol) and diisopropylethylamine (0.063 mL, 0.36 mmol) in CH2Cl2 (1 mL) was cooled to 0° C. Methyl chloroformate (0.024 mL, 0.31 mmol) was added dropwise, and then the reaction was allowed to warm to room temperature and stir overnight. The reaction was diluted with CH2Cl2 (20 mL) and washed with brine (10 mL). The organic phase was dried over Na2SO4, filtered, and concentrated in vacuo. The crude product was then suspended in a 1:2 mixture of Et2O:THF (6 mL). A solution of LiAlH4 in Et2O (0.34 mL of a 1 M solution, 0.34 mmol) was added dropwise, and then the reaction mixture was heated to reflux for 1.5 h. The reaction was cooled, diluted with additional Et2O (8 mL), and quenched with Na2SO45H2O (0.98 g, 4.2 mmol). After stirring for 15 minutes, the mixture was filtered and the reaction was concentrated in vacuo. A portion of this crude aniline (0.0580 g, 0.281 mmol) was dissolved in (CH2Cl)2 (8 mL), and 7-chloro-5-(2-chlorophenyl)-1,3-dihydro-3-isothiocyanato-1-methyl-2H-1,4-benzodiazepin-2-one (0.106 g, 0.281 mmol) was added. The resulting mixture was heated at 70° C. for 14 h. The reaction was cooled and concentrated in vacuo, and the residue was purified by silica gel column chromatography (7:1 CH2Cl2:EtOAc) to provide the title compound (0.1211 g, 74%). Due to hindered rotation about one of the bonds, rotamers were observed in the 1H-NMR spectrum. 1H-NMR (CDCl3): δ 7.77-7.68 (m, 1H), 7.51 (dd, J=2.4 Hz, J=8.8 Hz, 1H), 7.43-7.36 (m, 2H), 7.34-7.28 (m, 2H), 7.16 (t, J=8.4 Hz, 1H), 7.10-7.01 (m, 2H), 6.86-6.76 (m, 2H), 6.14 and 6.10 (2×d, J=8.0 Hz, J=7.6 Hz, 1H), 3.88-3.82 (br m, 4H), 3.60 and 3.59 (2×s, 3H), 3.41 (s, 3H), 3.19 (br s, 4H), 2.24 and 2.23 (2×s, 3H). MS (ESI) (M+H)+=582. HRMS calculated for (C29H29Cl2N5O2S+H) (M+H)+: 582.1497. Found (ESI): 582.1448.

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS07375101B2
Source datasetuspto-grants-2008_05
ORD IDord-13ff327a9c3f4d4095ec6b37a45d3ea3
Source noteuspto-grants-2008_05